KalVista Pharmaceuticals, Inc. (KALV) Net Income (Loss) Attributable to Parent USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending January 31, 2024 was -$29 M, a 36.3% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending January 31, 2024 was -$108 M, a 19.4% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$92.9 M, a 12.8% decline from 2021.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$82.3 M, a 78.1% decline from 2020.
  • KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$46.2 M, a 58.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$108 M -$29 M -$7.73 M -36.3% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 -$101 M -$27.7 M -$5.39 M -24.2% Aug 1, 2023 Oct 31, 2023 10-Q 2024-03-11
Q2 2023 -$95.2 M -$25.3 M -$2.28 M -9.87% May 1, 2023 Jul 31, 2023 10-Q 2024-03-11
Q1 2023 -$92.9 M -$26.3 M -$2.19 M -9.09% Feb 1, 2023 Apr 30, 2023 10-K 2023-07-10
Q4 2022 -$90.7 M -$21.3 M +$1.16 M +5.18% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 -$91.9 M -$22.3 M -$2.61 M -13.3% Aug 1, 2022 Oct 31, 2022 10-Q 2024-03-11
Q2 2022 -$89.3 M -$23 M -$6.93 M -43% May 1, 2022 Jul 31, 2022 10-Q 2024-03-11
Q1 2022 -$82.3 M -$24.1 M -$9.16 M -61.2% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-10
Q4 2021 -$73.2 M -$22.5 M -$12.4 M -124% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 -$60.8 M -$19.7 M -$9.22 M -88.5% Aug 1, 2021 Oct 31, 2021 10-Q 2023-03-09
Q2 2021 -$51.5 M -$16.1 M -$5.3 M -49% May 1, 2021 Jul 31, 2021 10-Q 2023-03-09
Q1 2021 -$46.2 M -$15 M -$8.37 M -127% Feb 1, 2021 Apr 30, 2021 10-K 2023-07-10
Q4 2020 -$37.9 M -$10 M -$757 K -8.15% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-10
Q3 2020 -$37.1 M -$10.4 M -$4.52 M -76.6% Aug 1, 2020 Oct 31, 2020 10-Q 2022-03-10
Q2 2020 -$32.6 M -$10.8 M -$3.48 M -47.4% May 1, 2020 Jul 31, 2020 10-Q 2022-03-10
Q1 2020 -$29.1 M -$6.59 M +$1.94 M +22.8% Feb 1, 2020 Apr 30, 2020 10-K 2020-07-01
Q4 2019 -$31.1 M -$9.29 M -$5.34 M -135% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 -$25.7 M -$5.9 M -$2.6 M -78.7% Aug 1, 2019 Oct 31, 2019 10-Q 2021-03-11
Q2 2019 -$23.1 M -$7.34 M -$2.31 M -45.9% May 1, 2019 Jul 31, 2019 10-Q 2021-03-11
Q1 2019 -$20.8 M -$8.53 M -$7.87 M -1198% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-01
Q4 2018 -$12.9 M -$3.96 M +$1.28 M +24.4% Nov 1, 2018 Jan 31, 2019 10-K 2020-07-01
Q3 2018 -$14.2 M -$3.3 M +$1.68 M +33.7% Aug 1, 2018 Oct 31, 2018 10-K 2020-07-01
Q2 2018 -$15.9 M -$5.03 M -$102 K -2.07% May 1, 2018 Jul 31, 2018 10-K 2020-07-01
Q1 2018 -$15.8 M -$657 K +$3.55 M +84.4% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-16
Q4 2017 -$19.4 M -$5.23 M +$2.41 M +31.5% Nov 1, 2017 Jan 31, 2018 10-K 2019-07-16
Q3 2017 -$21.8 M -$4.99 M -$2.6 M -109% Aug 1, 2017 Oct 31, 2017 10-K 2019-07-16
Q2 2017 -$19.2 M -$4.93 M +$2.42 M +33% May 1, 2017 Jul 31, 2017 10-K 2019-07-16
Q1 2017 -$21.6 M -$4.2 M +$2.41 M +36.4% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 -$24 M -$7.64 M -$1.99 M -35.1% Nov 1, 2016 Jan 31, 2017 10-K 2018-07-30
Q3 2016 -$22 M -$2.39 M +$2.61 M +52.2% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$24.6 M -$7.35 M +$1.66 M +18.4% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-12
Q1 2016 -$26.3 M -$6.61 M -$1.42 M -27.5% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$24.8 M -$5.66 M -$945 K -20% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 -$23.9 M -$4.99 M -$996 K -24.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$22.9 M -$9.01 M -$6.38 M -242% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$16.5 M -$5.18 M -$3.17 M -157% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$13.4 M -$4.71 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$4 M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-30
Q2 2014 -$2.64 M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-30
Q1 2014 -$2.02 M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.